Group items tagged

Infoholic's market research report predicts that the global leukemia therapeutics market will grow at a CAGR of 6.2% during the forecast period 2019-2025. Leukemia refers to the group of blood cancer that usually develops in the bone marrow, resulting in the formation of abnormal blood cells. Leukemia is subdivided into lymphoblastic or lymphocytic leukemias and myeloid or myelogenous leukemias that include acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML). The report provides complete details about the sub-segment of the global leukemia therapeutics market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

In the past several years, these cells were being used in various molecular and combinational therapies, which increased the adoption of such treatments. Furthermore, they can be used as an effective therapeutic tool against infectious diseases and as an anti-cancer alternative to T cells. Research activities are being carried out to culture NK cells in ex vivo conditions, thus consequently exploring and developing newer therapies for the treatment of infections and tumors.

Global arthritic therapeutic market growth is driven by increase in incidence of autoimmune disorders, rise in geriatric population, newer drugs in pipeline

Global Glaucoma Therapeutic Market - Market Size, Growth, Trends, Competitive Analysis, Market Share Analysis, Forecast - 2018-2025

Thigh Support Applications Mild support to quadriceps and hamstrings. Relieves inflammation and stiffness. Firm compression and therapeutic warmth. Psychological support to geriatric patients. Sports injury, sprains and strains. Post-surgical rehabilitation. Burn care. Thigh Support Features Strong Compression. Four way stretch. Dermophillic. Durable. Breathable and comfortable. Thigh Support Measurements Measure circumference around mid thigh - approximately 6 inches above knee. Size Chart - Size Inches CM Small 14.8 to 17.2 37 to 43 Medium 17.2 to 19.6 43 to 49 Large 19.6 to 22.0 49 to 55

Tynor Anklet (Pair) Anklets are tubular supports widely used in orthopedic practice to provide mild compression, warmth & support to the ankle joint, to allay pain and inflammation generally associated with old age, arthritis, sports etc. Four way stretch Two layered fabric Hypoallergenic Uniform compression Simple pull on application Tynor Anklet (Pair) Features Bilayered , cotton on the inside Dermophillic interpahse with the skin Better sweat absorption Better comfort Better patient compliance. No allergies or rash Bilayered, nylon on the outside Ensures long life Excellent aesthetics Color fastness. Two layers enclose air space retains body heat effectively Provides therapeutic warmth and assuring support to the knee. Four-way stretchable seamless tubular fabric Effective compression Enhanced comfort. No vaso constriction. Adjusts compression even on uneven diameters Simple pull on application improves patient compliance. Tynor Anklet (Pair) Measurements Measure circumference approx 2 inches above the ankle joint. Size Chart - Size Inches CM Small 7.2-8.4 18-21 Medium 8.4-9.6 21-24 Large 9.6-10.8 24-27 XL 10.8-12 27-30

Tynor Compression Stocking Below Knee Compression Stockings provide controlled compression to the legs to squeeze away abnormal back flow of blood into the superficial veins that lie just beneath the surface of the skin from the perforating veins. It is used in all forms of venous disease including blood pools or congests in legs. Severe varicose veins and discoloration to sores, ulcers and potentially life-threatening blood clots. Light weight. Four way stretch. Freely breathable. Soft and comfortable. Tynor Compression Stocking Below Knee Features Made from soft nylon yarn and spandex Strong and durable. Dermophillic. Optimal compression. Excellent aesthetics. Excellent Color fastness. Four-way stretchability Offers optimal compression. Snug fitting. Double layered Retains body heat effectively. Provides therapeutic warmth. Quicker healing. Strong and durable. Tapered shape and Controlled compression Uniform compression even on uneven limb surface. Offers graded compression high to low from toe upwards. Effective blood evacuation. Open toe design Reduces wear and tear. Easy to wear. Compatible to toe rings or other jewelry items. Tynor Compression Stocking Below Knee Measurements

To get relief from and treatment the of respiratory disease at hospitals, clinics, home, traveling and emergency situations various medical devices have been developed. The respiratory devices are used to provide medication to the lungs and supply the proper amount of ambient air or oxygen to a patient. Most of the devices are used as a non-invasive form of therapy for patients. Respiratory drugs and devices companies are concentrating on developing new products. Companies are expanding their product portfolios and increasing their R&D budget. Major respiratory devices include therapeutic devices such as masks, ventilators, humidifiers, positive airway pressure devices and other devices. Other respiratory devices include diagnostic and monitoring devices and consumables and accessories meters.

Sinus Dilation Devices Market

Companion diagnostics is a clinically established diagnostic tool used in conjunction with a therapeutic agent to identify the applicability of that drug to an individual patient. Companion diagnosis is generally the last step of drug management and usually involves a process of screening, evaluating, and prescribing medication based on the findings of companion diagnostics. A companion diagnose determines whether a particular drug therapy is suitable for the patient in terms of safety, toleration, and response to treatment. It is basically an advanced form of drug management that focuses on evaluating and implementing personalized treatment plans based on known medical issues and considerations. Increasing prevalence of cancer is expected to propel growth of the global companion diagnostics market over the forecast period. For instance, according to the American Cancer Society, in 2020, around 276,480 new cases of invasive breast cancer will be diagnosed in women and the disease will lead to around 42,170 deaths, in the U.S. Moreover, increasing development and commercialization of new products is also expected to aid in growth of the market. For instance, in November 2020, LabCorp announced an expanded agreement with BML, a leading Japanese provider of clinical laboratory testing services, to provide development and delivery of companion diagnostics in Japan. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/increasing-prevalence-of-cancer-and.html

MedRhythms, a US-based digital therapeutics company, has launched its five-site randomised controlled trial (RCT) at rehabilitation hospitals and research centres to examine a post-stroke walking rehabilitation device.

The global market for chronic kidney disease drugs is expected to witness single-digit growth during 2019-2025. The drug pipeline of chronic kidney disease looks promising with novel therapeutic approaches, such as cell therapy, likely to enhance the market growth opportunities. However, the competition from biosimilars and complex drug development processes are impeding the market growth. Over the period, extensive research is being done to fill the unmet needs' gap. The advances in the arena of regenerative treatment have come up with budding advancement of cell therapies that help regeneration and repairing of the kidneys. Cell therapy is proficient of refining the fundamental functioning capability of the kidney. Uncontrolled high blood pressure and diabetes are the leading causes of kidney failure globally.

Cardiovascular disease is a significant health concern worldwide despite having many genomics developments providing valuable new candidates for better biomarkers and novel therapeutic targets.

The single cell analysis market is predicted tocontrol the workflows with useful insights for detection of cancer and use new therapeutic strategies for well-beingof the patients. Single cell analysis is expected to steer to more effective and better analysis. Thus, increase in spending for research and development for cancer research is considered as factor boosting the growth of the single cell analysis market.

At ACL Digital Life Sciences, our clinical data managers are well-experienced in hosting EDCs or providing vendor oversight. Our clinical data managers have years of experience in multiple therapeutic areas across all Phase I-IV studies. We are highly qualified in CDISC compliance and SME-level expertise to produce results with the speed and accuracy you need.

The best pediatric cardiothoracic Fortis hospital in Delhi caters to a huge number of patients and offers diagnostic and therapeutic services and referrals to a surgical professional while wanted by offering a success rate in surgeries between 98 - 99%.